|
Re: like the song "AT LAST": her2+ breast cancer subtypes are being IDd, best treatme
Quote:
|
The PAMELA study led by Prat through the support of a Susan G. Komen Foundation grant, involving various Spanish sites coordinated by the SOLTI cooperative research group, will aim to address the latter. The PAMELA study's primary objective is to identify those patients with HER2-positive tumors who can be cured with anti-HER2 biological therapies without the need for chemotherapy
|
Let's hear it for Pamela! 
Hopeful |